The FDA reported that New York Wholesale Group (Hicksville, NY) recalled Zaarah Herbals Shatavari Powder because it has the potential to be contaminated with elevated levels of lead. Short term exposures to very low levels of lead may not elicit any symptoms. Increased blood lead levels may be the only apparent sign of lead exposure. Additional overt signs and symptoms of lead exposure are more likely with acute exposure to higher levels of lead. While lead can affect nearly every bodily system, its effects depend upon the amount and duration of lead exposure and age/ body weight. If a fetus is exposed to enough lead for a protracted period of time (e.g., weeks to months), permanent damage to the central nervous system may occur. The exposure can result in learning disorders, developmental defects, and other long-term health problems. For adults, chronic lead exposure is associated with kidney dysfunction, hypertension, increased risk of mortality from cardiovascular disease, and neurocognitive effects. Zaarah Herbals Shatavari Powder was distributed to retailers located in New York, New Jersey, and Connecticut between 10/21/2022 and 04/15/2024. The product is packaged in clear 100g (3.5oz) jars with a gold lid. The name ZAARAH HERBALS SHATAVARI POWDER is prominently displayed on the front of the jar. The UPC is 63502899940. Product codes included in the recall are Batch No: SR 04 Mfd. Date: JULY/2022, which can be found on the back panel of the bottle. No illnesses have been reported to date. The recall is the result of an analysis conducted by the Connecticut Department of Consumer Protection; Food & Standards Division that revealed the product contained elevated levels of lead. @ https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/new-york-wholesale-group-recalls-zaarah-herbals-shatavari-powder-because-possible-health-risk